ecancermedicalscience

Submit article

https://doi.org/10.3332/ecancer.2020.1076

Abstract | Full Article |

Short Communication

Cancer care during the COVID-19 pandemic: a perspective from Saudi Arabia

17 Jul 2020

Saleh A Alessy, Elizabeth A Davies, Abdul-Rahman Jazieh

The coronavirus disease 2019 (COVID-19) pandemic continues to disrupt many healthcare settings worldwide including cancer care. COVID-19 has been associated with worse outcomes amongst cancer patients. Saudi Arabia has experienced several Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks that affected the continuity of cancer care. In this paper, we describe how Saudi Arabia responded to COVID-19, how cancer care was re-restructured during this pandemic and how the recent MERS-CoV experience may have improved the Saudi response to COVID-19.

Article metrics: 2781 views

1839

942

1937-dehyart-trial-study-protocol-for-phase-2-randomised-controlled-study-assessing-the-role-of-dose-escalation-using-18f-fluoromisonidazole-positron-emission-tomography-computed-tomography-in-head-and-neck-cancers

Clinical Study: DEHyART trial: Study protocol for phase 2 randomised controlled study assessing the role of dose escalation using [18F] fluoromisonidazole positron emission tomography/computed tomography in head and neck cancers

Sarthak Tandon, Manoj Gupta, Parveen Ahlawat, Madhur Verma, Apoorva Nayak, Akash Bellige, Kundan S Chufal, Jaskaran S Sethi, Anjali Pahuja, Shreya Rai, Abhishek Singh, Vikas Arora, Vishal Yadav, David K Simson, Irfan Ahmad, Sandeep Singh, Dipesh Vashisht, Azhar Ansari, Rashmi Bansal, Abhishek Bhadri, Harsh Vyas, Manindra Mishra, Rajat Saha, Mudit Agarwal, Partha S Chowdhary, Ajay K Dewan, Munish Gairola

2 Jul 2025

https://doi.org/10.3332/ecancer.2025.1937

Abstract | Full Article | PDF